FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Aristo Bio-Tech and Lifescience IPO is a fixed price issue of Rs 13.05 crores. The issue is entirely a fresh issue of 18.13 lakh shares.
Aristo Bio-Tech and Lifescience IPO bidding started from January 16, 2023 and ended on January 19, 2023. The allotment for Aristo Bio-Tech and Lifescience IPO was finalized on Tuesday, January 24, 2023. The shares got listed on NSE SME on January 30, 2023.
Aristo Bio-Tech and Lifescience IPO price is ₹72 per share. The minimum lot size for an application is 1600 Shares. The minimum amount of investment required by retail investors is ₹115,200. The minimum lot size investment for HNI is 2 lots (3,200 shares) amounting to ₹230,400.
Beeline Capital Advisors Pvt Ltd is the book running lead manager of the Aristo Bio-Tech and Lifescience IPO, while Link Intime India Private Ltd is the registrar for the issue. The market maker for Aristo Bio-Tech and Lifescience IPO is Sunflower Broking.
Refer to Aristo Bio-Tech and Lifescience IPO RHP for detailed information.
IPO Date | January 16, 2023 to January 19, 2023 |
Listing Date | January 30, 2023 |
Face Value | ₹10 per share |
Price | ₹72 per share |
Lot Size | 1600 Shares |
Total Issue Size | 1,812,800 shares (aggregating up to ₹13.05 Cr) |
Fresh Issue | 1,812,800 shares (aggregating up to ₹13.05 Cr) |
Issue Type | Fixed Price Issue IPO |
Listing At | NSE SME |
Share holding pre issue | 4,995,000 |
Share holding post issue | 6,807,800 |
Market Maker portion | 91,200 shares Sunflower Broking |
Aristo Bio-Tech and Lifescience IPO offers 1,812,800 shares. 860,800 (47.48%) to NII, 860,800 (47.48%) to RII.
Investor Category | Shares Offered |
---|---|
Anchor Investor Shares Offered | - |
Market Maker Shares Offered | 91,200 (5.03%) |
Other Shares Offered | 860,800 (47.48%) |
Retail Shares Offered | 860,800 (47.48%) |
Total Shares Offered | 1,812,800 (100%) |
Aristo Bio-Tech and Lifescience IPO opens on January 16, 2023, and closes on January 19, 2023.
IPO Open Date | Monday, January 16, 2023 |
IPO Close Date | Thursday, January 19, 2023 |
Basis of Allotment | Tuesday, January 24, 2023 |
Initiation of Refunds | Wednesday, January 25, 2023 |
Credit of Shares to Demat | Friday, January 27, 2023 |
Listing Date | Monday, January 30, 2023 |
Cut-off time for UPI mandate confirmation | 5 PM on January 19, 2023 |
Investors can bid for a minimum of 1600 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 1600 | ₹115,200 |
Retail (Max) | 1 | 1600 | ₹115,200 |
HNI (Min) | 2 | 3,200 | ₹230,400 |
Lot Size Calculator |
Mr. Narendra Singh Barhat, Mrs. Kusum Narendra Singh Barhat and Mr. Ketankumar Harkantbhai Joshi are the promoters of the company.
Share Holding Pre Issue | 100.00% |
Share Holding Post Issue | 73.37% |
Incorporated in 2005, Aristo Bio-Tech and Lifescience Limited is an agrochemical company. They are mainly engaged in the manufacturing, formulation, supplying, packaging, and job work services of various Pesticides.
They deliver their products in India as well as engage in exporting products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators, and a wide variety of other Agrochemicals.
The industry Aristo Bio-Tech and Lifescience is engaged in, is full of possibilities where the entities deal in the production and distribution of pesticides and fertilizers. All these entities contribute towards enhancing crop yields and their quality.
Aristo Bio-Tech and Lifescience are delivering their products in over 20 states of India. Also, the offerings are extended to over 15 countries, including Armenia, Australia, Bangladesh, Belgium, Cambodia, Germany, Italy, Kenya, Moldova, New Zealand, Poland, South Africa, UAE, Ukraine, and Vietnam.
The company is ISO 9001: 2015 certified for their Quality Management System. Following are the products of Aristo:
Alongside undertaking manufacturing operations, the company also provide Contract manufacturing, Job work and Toll manufacturing services for Crop Protection companies.
Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
---|---|---|---|---|---|---|
31-Mar-20 | 8,785.12 | 20,123.94 | 100.74 | 1,230.51 | 731.01 | 1,970.97 |
31-Mar-21 | 8,141.73 | 16,722.96 | 107.57 | 1,338.08 | 838.58 | 2,224.77 |
31-Mar-22 | 7,700.16 | 16,603.29 | 146.17 | 1,484.25 | 984.75 | 2,548.43 |
30-Sep-22 | 10,869.14 | 12,907.49 | 258.90 | 1,743.15 | 1,243.65 | 2,935.53 |
Amount in ₹ Lakhs |
The market capitalization of Aristo Bio-Tech and Lifescience IPO is Rs 49.02 Cr.
Pre IPO | Post IPO | |
---|---|---|
P/E (x) | 9.46 |
The Net Proceeds from the Fresh Issue will be utilized towards the following objects:
[Dilip Davda] Based on its super earnings for H1 of FY23, the IPO is fully priced discounting all near-term positives. The sustainability of such margins going forward is a major concern. The segment too is becoming crowded and highly competitive. Post-IPO small paid-up equity also indicates longer gestation for migration to the main board. Well-informed investors may park funds with a long-term perspective. Read detail review...
The Aristo Bio-Tech and Lifescience IPO is subscribed 217.72 times on January 19, 2023 7:00:00 PM. The public issue subscribed 149.59 times in the retail category, times in the QIB category, and 285.84 times in the NII category. Check Day by Day Subscription Details (Live Status)
Category | Subscription (times) |
---|---|
Other | 285.84 |
Retail | 149.59 |
Total | 217.72 |
Listing Date | January 30, 2023 |
BSE Script Code | |
NSE Symbol | ARISTO |
ISIN | INE082101010 |
Final Issue Price | ₹72 per share |
Price Details |
---|
Final Issue Price |
Open |
Low |
High |
Last Trade |
NSE SME |
---|
₹72.00 |
₹80.00 |
₹76.05 |
₹84.00 |
₹84.00 |
Aristo Bio-Tech and Lifescience Limited
E-24,25,26, G.I.D.C. Manjusar,
Ta. Savli,
Vadodara – 391775
Phone: +91-2667-264843
Email: cs@aristobiotech.com
Website: http://www.aristobiotech.com/
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: aristobio.ipo@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html
SME Company Owners
We could help you get listed on the stock market.
Check our SME IPO Guide
Aristo Bio-Tech and Lifescience IPO is a SME IPO of 1,812,800 equity shares of the face value of ₹10 aggregating up to ₹13.05 Crores. The issue is priced at ₹72 per share. The minimum order quantity is 1600 Shares.
The IPO opens on January 16, 2023, and closes on January 19, 2023.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Aristo Bio-Tech and Lifescience IPO using UPI as a payment gateway. Zerodha customers can apply in Aristo Bio-Tech and Lifescience IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Aristo Bio-Tech and Lifescience IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Aristo Bio-Tech and Lifescience IPO opens on January 16, 2023 and closes on January 19, 2023.
Aristo Bio-Tech and Lifescience IPO lot size is 1600 Shares, and the minimum amount required is ₹115,200.
You can apply in Aristo Bio-Tech and Lifescience IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Aristo Bio-Tech and Lifescience IPO will be done on Tuesday, January 24, 2023, and the allotted shares will be credited to your demat account by Friday, January 27, 2023. Check the Aristo Bio-Tech and Lifescience IPO allotment status.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
The Manager-Listing
National Stock Exchange of India Limited
Exchange Plaza, Bandra Kurla Complex,
Mumbai – 400051
Respected Sir/Ma’am,
Sub: Update under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015.
Ref: Aristo Bio-Tech and Lifescience Limited (Symbol: - ARISTO, ISIN: - INE082101010)
In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are
pleased to inform that our Company has received Letter of Intent from National Fertilizers Limited (NFL), a
government of India undertaking stating tender for supply of various Agrochemicals on FOR basis at various state
warehouses of NFL.
The said receipt of Tender of worth Rs. 13.56 Crores would enhance the customer base and would attribute towards
profitability of the Company.
Further Details with respect to said order as required under regulation 30 of listing regulations read with SEBI circular
CIR/CFD/CMD/4/2015 dated September 09, 2015 are Provided herewith.
You are requested to kindly note the same.
Thanking you,
Yours faithfully,
For Aristo Bio-Tech And Lifescience Limited
Narendra Singh Barhat
(Chairman cum Managing Director)
DIN: 00310306
Place: Vadodara
Encl: A/a
NARENDRA
SINGH BARHAT
Digitally signed by
NARENDRA SINGH
BARHAT
Date: 2023.02.23
13:07:18 +05'30'